Disagree. Folks will see that more doctors are being trained the next few weeks and the smart ones will be buying these ridiculously low prices. Thus stock should be well into the pennies. Any buys below that will be richly rewarded. It is even more ridiculous to assert that CELZ has 2B more to dilute. They are bleeding off notes only to fund business. That need dwindles with each doctor signing up and generating revs.
Any investors digging a little will see Antonini is a rock star in Rome and has support from the ministry of health. Since he already reported he has treated 60 patients, and he has been in several articles and interviews, it is very logical to see that just his offices alone will be getting very very busy and word will spread all through Europe. His office alone will bring big revs.
It’s my opinion the same will happen in the CA, NM, and FL as these doctors are also reporting very excellent results and are happy to have this treatment vs. drugs or surgery. The word is simply spreading....finally.
No one is saying CaverStem can fix everyone every time, but it is an awesome new treatment, long overdue.
Articles are also popping up all over as stem cell treatments are all around.
CELZ low PPS is nothing more than being the victim of a slow mover in the OTC, having to issue some notes to pay the bills, and folks getting out after the false start in 2018.
ALL of those things have changed.... the training cadence has increased, the notes will be no more very soon, and buying vs selling will be the trade of the day as the market takes notice. Could be Tuesday, could be June, who knows, but I have no doubts it’s coming very soon, and these prices are a smart buy.
I am confident that CELZ will hit their mark of self sufficiency in 2019. Many things are planned the rest of the year. All IMO of course.
